⚠️ Beware of scams impersonating us. Read more.

Chief Medical Officer (Biotech)

Taipei City Permanent View Job Description
My client is seeking a CMO to lead the transition from a research-stage biotech into a clinical-stage company, with responsibility for global clinical strategy, RA engagement and first-in-human development activities. This role will oversee the advancement of innovative oncology-focused diagnostic and therapeutic radiopharmaceutical programs while building clinical development and medical capabilities from the ground up.
  • Lead a biotech's transition from preclinical to first-in-human studies
  • Shape a global theranostics strategy and build the clinical function

About Our Client

My client is an emerging biotechnology company developing targeted oncology therapies and molecular imaging approaches within the precision medicine and radiopharmaceutical space. The organisation is entering a pivotal phase of growth, moving from preclinical research into clinical development and creating the infrastructure required to support global studies.


The business offers the opportunity to work at the forefront of theranostics, integrating diagnostics and therapeutics to improve patient selection, treatment planning and clinical outcomes. With a highly entrepreneurial environment and significant scientific ambition, the organisation is seeking a senior physician leader capable of shaping strategy, influencing external stakeholders and helping define the long-term clinical direction of the company.

Job Description

  • Lead the overall clinical development strategy for oncology-focused radiopharmaceutical programmes, from first-in-human studies through proof-of-concept planning and future registration pathways.
  • Define indication prioritisation, patient selection approaches, biomarker integration, dose optimisation strategies and clinical development milestones.
  • Design and oversee early-phase clinical studies, including protocol development, dose-escalation methodologies and expansion cohort planning.
  • Direct clinical execution activities through investigator selection, site strategy, enrolment planning and CRO oversight.
  • Interpret and integrate clinical safety, pharmacokinetic, imaging, biodistribution and dosimetry data to inform programme decisions.
  • Establish a translational medicine framework connecting preclinical findings, biomarkers, molecular imaging and emerging clinical evidence.
  • Serve as the senior medical representative for interactions with health authorities and regulatory agencies, including scientific advice and submission-related activities.
  • Provide leadership for safety governance, pharmacovigilance processes, serious adverse event review and benefit-risk assessment frameworks.
  • Build and maintain relationships with oncology specialists, nuclear medicine experts, key opinion leaders and clinical advisors globally.
  • Create and scale core clinical functions including clinical development, medical monitoring, clinical operations, safety, biometrics and medical affairs.
  • Support executive decision-making related to portfolio strategy, licensing opportunities, business development assessments and strategic partnerships.

The Successful Applicant

  • Medical Doctor (MD) qualification.
  • Significant biotechnology and/or pharmaceutical industry experience in clinical development, ideally exceeding ten years.
  • Strong oncology drug development background with hands-on involvement in early-phase clinical trials.
  • Demonstrated experience designing and implementing first-in-human and dose-escalation studies.
  • Deep understanding of clinical safety, GCP, PK/PD principles, biomarkers and regulatory requirements.
  • Experience interacting directly with health authorities and contributing to regulatory submissions.
  • Ability to work strategically while remaining actively involved in execution within a growing organisation.

What's on Offer

  • Opportunity to join the executive leadership team of a biotechnology company at a transformational stage of growth.
  • Ownership of global clinical strategy and responsibility for taking innovative oncology assets into human studies.
  • Ability to shape both programme direction and organisational design from the outset.
  • Exposure to cutting-edge radiopharmaceutical and theranostic science with strong strategic impact.
  • Visibility across investors, regulators, academic leaders and potential partners.
  • Chance to build a clinical development organisation and leave a lasting imprint on the company's future growth.
Contact
Jenny I Wang
Quote job ref
JN-102026-7118155
Phone number
+886 2 8729 8235

Job summary

Job function
Life Sciences
Specialisation
Medical Affairs
What is your area of specialisation?
Healthcare / Pharmaceutical
Location
Taipei City
Contract Type
Permanent
Consultant name
Jenny I Wang
Consultant phone
+886 2 8729 8235
Job Reference
JN-102026-7118155

Diversity & Inclusion at Michael Page

We don't just accept difference - we celebrate it. We encourage applicants from all backgrounds to apply for this role and are committed to building inclusive, diverse workplaces where everyone can thrive. If you require any support or reasonable adjustments during the recruitment process, please let us know.